Robert J. Zollars

ROBERT J. ZOLLARS has been Chairman and Chief Executive Officer of
Neoforma, Inc., since July 1999. Since joining Neoforma, Mr. Zollars has
executed and overseen the company’s January 2000 initial public
offering, as well as its successful evolution to industry leader. From
1997 to 1999, Mr. Zollars served as Executive Vice President and Group
President of Cardinal Health, Inc., a $21 billion healthcare product and
service company. At Cardinal Health, Mr. Zollars was responsible for
five of the company’s wholly owned subsidiaries: Pyxis Corporation; Owen
Healthcare, Inc.; Medicine Shoppe International; Cardinal Information
Corporation; and the company’s international business. From 1992 to
1996, Mr. Zollars served as President of Hospital Supply, Scientific
Products and U.S. Distribution of Baxter Healthcare Corporation, where
he spearheaded the integration of Baxter’s medical-surgical and
diagnostics distribution business when the Hospital Supply Division
merged with Scientific Products. Before his appointment as President of
Hospital Supply, Mr. Zollars was President of I.V. Therapy, a $500
million strategic manufacturing division of Baxter, where he was
responsible for 7,000 employees worldwide and 11 manufacturing plants in
the United States and abroad. In 1996, shortly after the merger of
Baxter Travenol and American Hospital Supply Corporation, Mr. Zollars
was promoted to President of Dietary Products, where he was responsible
for designing, negotiating and implementing a joint-venture with Kraft
General Foods. Mr. Zollars graduated Magna Cum Laude with a Bachelor of
Science degree in Marketing from Arizona State University, and has a
Master of Business Administration degree in Finance from John F. Kennedy
University.